Does TALAZOPARIB Cause Pulmonary embolism? 20 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 20 reports of Pulmonary embolism have been filed in association with TALAZOPARIB (Talzenna). This represents 1.4% of all adverse event reports for TALAZOPARIB.
20
Reports of Pulmonary embolism with TALAZOPARIB
1.4%
of all TALAZOPARIB reports
5
Deaths
10
Hospitalizations
How Dangerous Is Pulmonary embolism From TALAZOPARIB?
Of the 20 reports, 5 (25.0%) resulted in death, 10 (50.0%) required hospitalization, and 4 (20.0%) were considered life-threatening.
Is Pulmonary embolism Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TALAZOPARIB. However, 20 reports have been filed with the FAERS database.
What Other Side Effects Does TALAZOPARIB Cause?
Anaemia (219)
Neoplasm progression (169)
Death (142)
Off label use (78)
Thrombocytopenia (78)
Fatigue (77)
Platelet count decreased (68)
Haemoglobin decreased (65)
Febrile neutropenia (60)
Pancytopenia (60)
What Other Drugs Cause Pulmonary embolism?
RIVAROXABAN (3,282)
LENALIDOMIDE (2,976)
APIXABAN (2,714)
ETHINYL ESTRADIOL\ETONOGESTREL (2,370)
TESTOSTERONE (2,043)
RITUXIMAB (1,764)
ADALIMUMAB (1,663)
PREDNISONE (1,586)
METHOTREXATE (1,508)
DEXAMETHASONE (1,336)
Which TALAZOPARIB Alternatives Have Lower Pulmonary embolism Risk?
TALAZOPARIB vs TALC
TALAZOPARIB vs TALIGLUCERASE ALFA
TALAZOPARIB vs TALIMOGENE LAHERPAREPVEC
TALAZOPARIB vs TALQUETAMAB
TALAZOPARIB vs TALQUETAMAB-TGVS